Avenzo Therapeutics, Inc.

🇺🇸United States

Country: 🇺🇸United States

Ownership: Holding

Employees: -

Market Cap: -

Website: https://avenzotx.com

Clinical Trials

Study of AVZO-021 in Patients With Advanced Solid Tumors

Phase 1

Recruiting

Conditions: Advanced Solid Tumor

Interventions: Drug: AVZO-021
Drug: Palbociclib
Drug: Fulvestrant
Drug: Letrozole
Drug: Ribociclib
Drug: Abemaciclib
Drug: Carboplatin

First Posted Date: 2023-05-19

Last Posted Date: 2024-05-30

Lead Sponsor: Avenzo Therapeutics, Inc.

Target Recruit Count: 430

Registration Number: NCT05867251

Locations: 🇺🇸
NEXT Virginia, Fairfax, Virginia, United States
🇺🇸
Florida Cancer Specialists, Sarasota, Florida, United States
🇺🇸
Sidney Kimmel Cancer Center (SKCC) at Jefferson Health, Philadelphia, Pennsylvania, United States

and more 3 locations

Prev
1
Next

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy